SEC Form 4 · accession 0001185185-17-000082
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director
Period of report
Jan 13, 2017
Accepted (ET)
Jan 17, 2017 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Jan 13, 2017 | D | 34,400 | $0.383 | D | 197,889 | I | By spouse |
| Common stockF2 | Jan 13, 2017 | D | 14,400 | $0.37 | D | 183,889 | I | By spouse |
| Common stockF2 | Jan 13, 2017 | D | 1,600 | $0.40 | D | 182,289 | I | By spouse |
| Common stockF2 | Jan 13, 2017 | A | 330,000 | $0.00 | A | 512,289 | I | By spouse |
| Common stockF1 | Jan 13, 2017 | A | 807,433 | $0.00 | A | 1,426,950 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.
- F2Represents shares held directly by Parveen Mukunda.